Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin

Virology

Volumn 410, Issue 1, 2011, Pages 64-75

  Lu, Jie ^a   Murakami, Masanao ^a   Verma, Subhash C ^a   Cai, Qiliang ^a   Haldar, Sabyasachi ^a   Kaul, Rajeev ^a   Wasik, Mariusz A ^b   Middeldorp, Jaap ^c   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; EBNA1; Oncogenic process; Sp1; Survivin

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; SURVIVIN; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

APOPTOSIS; B-LYMPHOCYTES; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 78650746034     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.029     Document Type: Article

References (68)

1. Altieri D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 2003, 3(1):46-54.
2. Altieri D.C. New wirings in the survivin networks. Oncogene 2008, 27(48):6276-6284.
3. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997, 3(8):917-921.
4. Boidot R., Vegran F., Jacob D., Chevrier S., Cadouot M., Feron O., Solary E., Lizard-Nacol S. The transcription factor GATA-1 is overexpressed in breast carcinomas and contributes to survivin upregulation via a promoter polymorphism. Oncogene 2010, 29(17):2577-2584.
5. Borbely A.A., Murvai M., Konya J., Beck Z., Gergely L., Li F., Veress G. Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J. Gen. Virol. 2006, 87(Pt 2):287-294.
6. Canaan A., Haviv I., Urban A.E., Schulz V.P., Hartman S., Zhang Z., Palejev D., Deisseroth A.B., Lacy J., Snyder M., Gerstein M., Weissman S.M. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc. Natl Acad. Sci. USA 2009, 106(52):22421-22426.
7. Chang E., Donahue J., Smith A., Hornick J., Rao J.N., Wang J.Y., Battafarano R.J. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. J. Thorac. Cardiovasc. Surg. 2010, 140(1):225-232.
8. Chen J.S., Liu J.C., Shen L., Rau K.M., Kuo H.P., Li Y.M., Shi D., Lee Y.C., Chang K.J., Hung M.C. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther. 2004, 11(11):740-747.
9. Cheng T.C., Hsieh S.S., Hsu W.L., Chen Y.F., Ho H.H., Sheu L.F. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Int. J. Oncol. 2010, 36(1):151-160.
10. Chun J.Y., Hu Y., Pinder E., Wu J., Li F., Gao A.C. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Mol. Cancer Ther. 2007, 6(9):2572-2580.
11. Davenport M.G., Pagano J.S. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J. Virol. 1999, 73(4):3154-3161.
12. Fodde R., Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 2007, 19(2):150-158.
13. Gahn T.A., Sugden B. An EBNA-1-dependent enhancer acts from a distance of 10kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 1995, 69(4):2633-2636.
14. Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl Acad. Sci. USA 2009, 106(7):2313-2318.
15. Hammerschmidt W., Sugden B. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease. Trends Mol. Med. 2004, 10(7):331-336.
16. Hino R., Uozaki H., Inoue Y., Shintani Y., Ushiku T., Sakatani T., Takada K., Fukayama M. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Cancer Res. 2008, 68(5):1427-1435.
17. Holowaty M.N., Zeghouf M., Wu H., Tellam J., Athanasopoulos V., Greenblatt J., Frappier L. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 2003, 278(32):29987-29994.
18. Hong M., Murai Y., Kutsuna T., Takahashi H., Nomoto K., Cheng C.M., Ishizawa S., Zhao Q.L., Ogawa R., Harmon B.V., Tsuneyama K., Takano Y. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. J. Cancer Res. Clin. Oncol. 2006, 132(1):1-8.
19. Hung S.C., Kang M.S., Kieff E. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc. Natl Acad. Sci. USA 2001, 98(4):1865-1870.
20. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 1998, 72(5):4371-4378.
21. Kang M.S., Lu H., Yasui T., Sharpe A., Warren H., Cahir-McFarland E., Bronson R., Hung S.C., Kieff E. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc. Natl Acad. Sci. USA 2005, 102(3):820-825.
22. Kapoor P., Lavoie B.D., Frappier L. EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol. Cell. Biol. 2005, 25(12):4934-4945.
23. Kaul R., Murakami M., Choudhuri T., Robertson E.S. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J. Virol. 2007, 81(19):10352-10361.
24. Kawakami H., Tomita M., Matsuda T., Ohta T., Tanaka Y., Fujii M., Hatano M., Tokuhisa T., Mori N. Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax. Int. J. Cancer 2005, 115(6):967-974.
25. Kennedy G., Komano J., Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl Acad. Sci. USA 2003, 100(24):14269-14274.
26. Knight J.S., Cotter M.A., Robertson E.S. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. J. Biol. Chem. 2001, 276(25):22971-22978.
27. Kobayashi K., Hatano M., Otaki M., Ogasawara T., Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc. Natl Acad. Sci. USA 1999, 96(4):1457-1462.
28. Lee C.W., Raskett C.M., Prudovsky I., Altieri D.C. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res. 2008, 68(13):5273-5281.
29. Leight E.R., Sugden B. EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev. Med. Virol. 2000, 10(2):83-100.
30. Li F., Altieri D.C. Transcriptional analysis of human survivin gene expression. Biochem. J. 1999, 344(Pt 2):305-311.
31. Lin A., Wang S., Nguyen T., Shire K., Frappier L. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J. Virol. 2008, 82(24):12009-12019.
32. Lu J., Verma S.C., Murakami M., Cai Q., Kumar P., Xiao B., Robertson E.S. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-associated B-lymphoma cells and contributes to their proliferation. J. Virol. 2009, 83(14):7129-7141.
33. Marechal V., Dehee A., Chikhi-Brachet R., Piolot T., Coppey-Moisan M., Nicolas J.C. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J. Virol. 1999, 73(5):4385-4392.
34. Marusawa H., Matsuzawa S., Welsh K., Zou H., Armstrong R., Tamm I., Reed J.C. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 2003, 22(11):2729-2740.
35. Murakami M., Lan K., Subramanian C., Robertson E.S. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J. Virol. 2005, 79(3):1559-1568.
36. Nayyar V.K., Shire K., Frappier L. Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J. Cell Sci. 2009, 122(Pt 23):4341-4350.
37. Nilsson T., Zetterberg H., Wang Y.C., Rymo L. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. J. Virol. 2001, 75(13):5796-5811.
38. O'Neil J.D., Owen T.J., Wood V.H., Date K.L., Valentine R., Chukwuma M.B., Arrand J.R., Dawson C.W., Young L.S. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J. Gen. Virol. 2008, 89(Pt 11):2833-2842.
39. Pina-Oviedo S., Urbanska K., Radhakrishnan S., Sweet T., Reiss K., Khalili K., Del Valle L. Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am. J. Pathol. 2007, 170(4):1291-1304.
40. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 2002, 12(6):431-441.
41. Riccardi C., Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 2006, 1(3):1458-1461.
42. Rickinson A.B., Kieff E. Epstin-Barr virus. Fields Virology 1996, 2397-2466. Lippincott-Raven Publisher, Philadelphia, PA. 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
43. Rickinson A.B., Kieff E. Epstein-Barr virus. Fields Virology 2001, 2575-2627. Lippincott/The Williams & Wilkins Co., Philadelphia, PA. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
44. Saridakis V., Sheng Y., Sarkari F., Holowaty M.N., Shire K., Nguyen T., Zhang R.G., Liao J., Lee W., Edwards A.M., Arrowsmith C.H., Frappier L. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 2005, 18(1):25-36.
45. Sarkari F., Sanchez-Alcaraz T., Wang S., Holowaty M.N., Sheng Y., Frappier L. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog. 2009, 5(10):e1000624.
46. Sears J., Ujihara M., Wong S., Ott C., Middeldorp J., Aiyar A. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 2004, 78(21):11487-11505.
47. Sivachandran N., Sarkari F., Frappier L. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 2008, 4(10):e1000170.
48. Subramanian C., Cotter M.A., Robertson E.S. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat. Med. 2001, 7(3):350-355.
49. Sugden B., Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 1989, 63(6):2644-2649.
50. Sung N.S., Wilson J., Davenport M., Sista N.D., Pagano J.S. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell. Biol. 1994, 14(11):7144-7152.
51. Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., Reed J.C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998, 58(23):5315-5320.
52. Tsimbouri P., Drotar M.E., Coy J.L., Wilson J.B. bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene 2002, 21(33):5182-5187.
53. Valentine R., Dawson C.W., Hu C., Shah K.M., Owen T.J., Date K.L., Maia S.P., Shao J., Arrand J.R., Young L.S., O'Neil J.D. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol. Cancer 2010, 9:1.
54. Verma S.C., Robertson E.S. ORF73 of herpesvirus Saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats. J. Virol. 2003, 77(23):12494-12506.
55. Verma S.C., Choudhuri T., Kaul R., Robertson E.S. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J. Virol. 2006, 80(5):2243-2256.
56. Verma S.C., Choudhuri T., Robertson E.S. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner. J. Virol. 2007, 81(7):3402-3413.
57. Wilson J.B., Bell J.L., Levine A.J. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J. 1996, 15(12):3117-3126.
58. Wood V.H., O'Neil J.D., Wei W., Stewart S.E., Dawson C.W., Young L.S. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 2007, 26(28):4135-4147.
59. Wu H., Ceccarelli D.F., Frappier L. The DNA segregation mechanism of Epstein-Barr virus nuclear antigen 1. EMBO Rep. 2000, 1(2):140-144.
60. Yang L., Cao Z., Li F., Post D.E., Van Meir E.G., Zhong H., Wood W.C. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther. 2004, 11(15):1215-1223.
61. Yates J.L. Dissection of DNA replication and enhancer activation functions of Epstein-Barr virus nuclear antigen 1. Cancer Cell 1988, 6:197-205.
62. Yates J.L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985, 313(6005):812-815.
63. Yates J.L., Camiolo S.M., Ali S., Ying A. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 1996, 222(1):1-13.
64. Yin Q., Flemington E.K. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells. Virology 2006, 346(2):385-393.
65. Young L.S., Rickinson A.B. Epstein-Barr virus: 40years on. Nat. Rev. Cancer 2004, 4(10):757-768.
66. Zhang X., Dong N., Yin L., Cai N., Ma H., You J., Zhang H., Wang H., He R., Ye L. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. J. Med. Virol. 2005, 77(3):374-381.
67. Zhou Y., Gong G.Z. Hepatitis C virus NS5A protein upregulates survivin gene expression. Zhonghua Gan Zang Bing Za Zhi 2006, 14(6):414-417.
68. Zhu Y., Roshal M., Li F., Blackett J., Planelles V. Upregulation of survivin by HIV-1 Vpr. Apoptosis 2003, 8(1):71-79.